UroCareLive

LUGPA Series

LUGPA Virtual Crossfire Discussion and Debate Series


Presentations

  • NON
    CME

    Establishing an Advanced Bladder Cancer Clinic

    Speakers:Noah M. Hahn, MD, Associate Professor of Medicine, Department of Oncology and Urology; Director, Medical Oncology Bladder Cancer Program
    Ashish M. Kamat, MD, MBBS, FACS, Professor of Urology; Wayne B. Duddlesten Professor in Cancer Research, Division of Surgery
    Jonathan Henderson, MD, CEO
    Neal D. Shore, MD, FACS, President

    Duration: 60 minutes

    Presented on: October 16, 2017

    *This session is not eligible for AMA PRA Category 1 CreditsTM

  • NON
    CME

    Future of Urology Practices: Independent, Hospital-Owned or Private Equity

    Speakers:David C. Chaikin, MD, Urologist
    Michael D. Fabrizio, MD, FACS, CEO
    Earl L. Walz, CEO
    Neal D. Shore, MD, FACS, President

    Duration: 60 minutes

    Presented on: August 31, 2017

    *This session is not eligible for AMA PRA Category 1 CreditsTM

  • NON
    CME

    Developing an Effective Advanced Prostate Cancer Clinic

    Speakers:Earl L. Walz, CEO
    Bryan A. Mehlhaff, MD, Urologist
    Bob Asinof, CEO
    Paul R. Sieber, MD, President and Medical Director of Research
    Neal D. Shore, MD, FACS, President

    Duration: 60 minutes

    Presented on: June 27, 2017

    *This session is not eligible for AMA PRA Category 1 CreditsTM


Speakers

  • Noah M. Hahn, MD

    Noah M. Hahn, MD

    Noah M. Hahn, MD

    Associate Professor of Medicine, Department of Oncology and Urology; Director, Medical Oncology Bladder Cancer Program

    Noah M. Hahn, MD, is an associate professor in the departments of oncology and urology, and director of the Medical Oncology Bladder Cancer Program at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland. Dr Hahn sees patients with urothelial cancers, including non-muscle invasive bladder cancer, and provides care to patients with non-urothelial genitourinary malignancies, including prostate, testicular, and other rare tumors. He is the bladder cancer chairman of the Eastern Cooperative Oncology Group, co-chairs the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, is a member of the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.
  • Ashish M. Kamat, MD, MBBS, FACS

    Ashish M. Kamat, MD, MBBS, FACS

    Ashish M. Kamat, MD, MBBS, FACS

    Professor of Urology; Wayne B. Duddlesten Professor in Cancer Research, Division of Surgery

    Ashish M. Kamat, MD, MBBS, is a professor of urology, Wayne B. Duddlesten Professor of Cancer Research, Division of Surgery, and director of the Urologic Oncology Fellowship at MD Anderson Cancer Center in Houston, Texas. Dr Kamat is an international expert in urologic oncology with an emphasis on bladder cancer, immunotherapy, organ-sparing and minimally invasive techniques. He maintains an active research portfolio in this area with a focus on efforts to develop novel therapies and identifying predictors of response to therapy as a first step towards personalized cancer therapeutics. Dr Kamat has authored numerous editorials, book chapters, publications in peer-reviewed journals, serves on the editorial board of high-ranked journals, and is involved in various professional organizations.
  • Jonathan Henderson, MD

    Jonathan Henderson, MD

    Jonathan Henderson, MD

    CEO

    Jonathan Henderson, MD, is the CEO of Regional Urology, LLC in Shreveport, Louisiana. He received his MD at Louisiana State University Medical Center (LSUMC) in Shreveport, and he completed his internship and residency in urology at LSUMC Hospital. Dr Henderson spent the following 6 years in practice in Alabama, specializing in treating disorders of the female bladder and laparoscopy. During this time, he served as a representative of Alabama to the Southeastern Section of the American Urology Association, and was an assistant clinical professor of urology at the University of Alabama. Dr Henderson is a member of the American Urologic Association, Shreveport Medical Society, Louisiana State Medical Society, Society of Laparoscopic Surgeons, and the Alpha Omega Alpha Medical Honor Society.
  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    President

    Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 250 clinical trials that focus mainly on GU oncology, serves on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 125 peer-reviewed publications, several book chapters, and is a peer reviewer for Lancet Oncology, Urology, and numerous other journals. He earned his MD from Duke University Medical School.
  • David C. Chaikin, MD

    David C. Chaikin, MD

    David C. Chaikin, MD

    Urologist

    David Chaikin, MD, is an urologist with Garden State Urology in Whippany, New Jersey, specializing in urogynecology and female reconstructive pelvic medicine, and male voiding dysfunction. He received his medical degree from the Albert Einstein College of Medicine in Bronx, New York, and completed his general surgery fellowship and urology residency at the Hospital of the University of Pennsylvania in Philadelphia. He is affiliated with Morristown Medical Center in Morristown, New Jersey and Weill Cornell Medical College in New York. Dr Chaikin’s specific areas of interest are urogynecology, male and female incontinence, genital prolapse, and neurologic disorders affecting the bladder.
  • Michael D. Fabrizio, MD, FACS

    Michael D. Fabrizio, MD, FACS

    Michael D. Fabrizio, MD, FACS

    CEO

    Michael D. Fabrizio, MD, FACS, is the CEO of Urology of Virginia, as well as professor of urology and endourology fellowship director at Eastern Virginia Medical School in Virginia Beach. Dr Fabrizio specializes in urological laparoscopy for benign and malignant conditions, including prostate and kidney cancer, adrenal surgery, kidney donation, and complex kidney and ureteral stone surgery. He is currently president-elect of the Mid-Atlantic Section of the American Urological Association, and a member of the American Urological Association, Endourology Society, and the Society of Urologic Oncology. He earned his medical degree from the Medical College of Virginia, and completed his residencies in surgery and urology at the Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.
  • Earl L. Walz

    Earl L. Walz

    Earl L. Walz

    CEO

    Earl L. Walz is chief executive officer of The Urology Group in Cincinnati, Ohio. Prior to joining The Urology Group, he was chief operating officer of the Urology Specialists, served as chief administrative consultant at the Northern Kentucky Multi Specialty Practice, and was chief operating officer of the Hoxworth Blood Center in Cincinnati. A certified medical practice executive, he is a member of several corporate and government medical advisory boards, and is a co-founder of the Large Urology Group Practice Association. He received his master’s degree in business administration from Xavier University in Cincinnati and a bachelor of science degree from the Northern Kentucky University in Highland Heights.
  • Bryan A. Mehlhaff, MD

    Bryan A. Mehlhaff, MD

    Bryan A. Mehlhaff, MD

    Urologist

    Bryan A. Mehlhaff, MD, is currently an urologist in private practice at Oregon Urology Institute in Springfield, where he also serves as the research medical director. Prior to joining Oregon Urology Institute, Dr Mehlhaff was an assistant professor of surgery in the division of urology at Albany Medical College in Albany, New York, where he honed his skills in adult and pediatric urology, endourology, and minimally invasive surgery. He serves on multiple urologic medical advisory boards and is a board member of the Large Urology Practice Association (LUGPA). Dr Mehlhaff has an active and ongoing interest in the latest therapeutics in advanced prostate cancer. He earned his medical degree from Oregon Health Sciences University, School of Medicine, in Portland.
  • Bob Asinof

    Bob Asinof

    Bob Asinof

    CEO

    Bob Asinof is the CEO of the Urology Center of Colorado in Denver. Mr Asinof has been the administrator of the group since 1992, and has 30 years of experience in the health care industry in hospital finance and physician group practice management. He currently also serves as treasurer of the Large Urology Group Practice Association (LUGPA), is a member of the Healthcare Financial Management Association as well as the Medical Group Management Association. He earned his Master of Science degree in health administration from the University of Colorado in Denver.
  • Paul R. Sieber, MD

    Paul R. Sieber, MD

    Paul R. Sieber, MD

    President and Medical Director of Research

    Paul R. Sieber, MD, is a practicing urologist based in Lancaster, Pennsylvania, and currently serves as president and the medical director of research for Lancaster Urology. Dr Sieber, who focuses primarily on prostate cancer, serves as the principal investigator for all of the clinical trials at Lancaster Urology. Having served as a principal investigator in more than 200 trials, he is enthusiastic about clinical trials and research as he looks at what can benefit his patients in the future. Dr Sieber earned his medical degree from the Indiana University-Purdue University at Indianapolis.